Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) (Middle Region) Peptide
LGALS9
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5512361
Quick Overview for Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) (Middle Region) Peptide (ABIN5512361)
Target
Galectin 9 (LGALS9)
(Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- YVVCNTRQNG SWGPEERKTH MPFQKGMPFD LCFLVQSSDF KVMVNGILFV
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-LGALS9 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
-
Background
-
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS9 is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency.
Protein Size: 323 -
Gene ID
- 3965
Target
-
You are here:
